Wang, Melinda
Silva, Tatiana
Toothaker, Jessica M.
McCourt, Blake T.
Shugrue, Christine
Desir, Gary
Gorelick, Fred
Konnikova, Liza
Funding for this research was provided by:
National Institutes of Health
U.S. Department of Defense
Article History
Received: 5 November 2021
Accepted: 7 March 2022
First Online: 23 March 2022
Competing interests
: GD is a named inventor on several issued patents related to the discovery and therapeutic use of renalase. Renalase is licensed to Bessor Pharma, and GD holds an equity position in Bessor and its subsidiary Personal Therapeutics. There are no other competing interests for this manuscript.